FDA 483 - Fujifilm Corporation - July 09, 2018

The provided document describes the general purpose and legal basis for an FDA Form 483, referencing Section 704(b) of the Federal Food, Drug and Cosmetic Act. It clarifies that these reports communicate objectionable conditions or practices observed during an inspection to assist firms in complying with regulations enforced by the Food and Drug Administration. The text is boilerplate information released under a FOIA request (2018-6794 on 05/30/2019). However, it does not contain specific details such as a company name, actual inspection dates, main violations or issues discovered at a particular facility, or any specific required actions. Therefore, a summary detailing a specific FDA 483 inspection cannot be generated from the provided content.